PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Oct-2024 Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group Pentixapharm Holding AG
25-Oct-2024 Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents Relief Therapeutics Holding SA
25-Oct-2024 STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2024 STRATEC SE
24-Oct-2024 Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024 Heidelberg Pharma AG
24-Oct-2024 QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery QUANTRO Therapeutics GmbH
24-Oct-2024 Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook 2024 Lonza Group AG
24-Oct-2024 Galenica increases sales growth in the third quarter Galenica AG
24-Oct-2024 Strategy EVOLVE+ paves the way for continued profitable growth Siegfried AG
23-Oct-2024 Ten businesses embark on Discovery Park’s ‘Discovery Spark’ programme Discovery Park
23-Oct-2024 Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset Angelini Pharma
23-Oct-2024 Analysis of Pharmaceutical Contract Manufacturing and Research Services Market Size by Research Nester Reveals the Market to Register with a CAGR of ~7.5% During 2025-2037 and Reach ~USD 632.9 billion by 2037 Research Nester
23-Oct-2024 AMYRA Successfully Demonstrates a New Therapeutic Paradigm for Gluten-Related Disorders in a First-in-Human Study AMYRA Biotech
23-Oct-2024 Evotec and Bristol Myers Squibb expand proteomics partnership Evotec SE
22-Oct-2024 aap Implantate AG: Cash capital increase and intended non-cash capital increase aap Implantate AG
22-Oct-2024 Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis Immunic AG
22-Oct-2024 Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates Lonza Group AG
21-Oct-2024 Medacta unveils the extended enhancements to its Hip Revision Platform Medacta Group SA
21-Oct-2024 Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update Mainz BioMed N.V.
21-Oct-2024 Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment Relief Therapeutics Holding SA
19-Oct-2024 Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM) Pentixapharm Holding AG